Wilms' Tumor 1(WT1) (PT0264) ?mouse monoclonal ?antibody
應(yīng)用:IHC-p 1:100-500,WB 1:500-2000?
產(chǎn)品名(Product Name)
Wilms' Tumor 1(WT1) (PT0264) mouse Monoclonal Antibody
貨號(hào)(Catalog No.)
KL-19649
種類(lèi)(Category)
Primary antibodies
宿主(Host)
Mouse/IgG1, Kappa
反應(yīng)種屬(Species specificity)
Human
應(yīng)用實(shí)驗(yàn)(Tested applications)
IHC-p,WB
克隆性(Clonality)
Monoclonal
偶連物(Conjugation)
Unconjugated
免疫原(Immunogen)
Synthesized peptide derived from human Wilms' Tumor 1(WT1)
狀態(tài)(Form)
Liquid
儲(chǔ)存溶液(Buffer)
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
存放條件(Storage)
-20°C/1 year
純化方式(Purity)
The antibody was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen.
產(chǎn)品背景:Wilms tumor 1(WT1) Homo sapiens This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015],?
特別提示:本公司的所有產(chǎn)品僅可用于科研實(shí)驗(yàn),嚴(yán)禁用于臨床醫(yī)療及其他非科研用途!?